Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2020 Jan 25;107(1):194–201. doi: 10.1016/j.ijrobp.2020.01.007

Fig. 1.

Fig. 1.

Chloro-2’-deoxyuridine (CldU) incorporation into NSC11 xenografts. On day 28 postimplantation, daily CldU treatment was initiated (100 mg/kg, intraperitoneal). Mice were euthanized 2 hours after the last injection. (A) Representative coronal images collected after 2 and 4 days of CldU delivery. (B) Representative high magnification images. (C) CldU+ tumor cells in each location (right hemisphere) as a function of the days of CldU treatment. Each point corresponds to an individual mouse with at least 200 cells analyzed (mean ±standard error of the mean for 4–5 mice).